Endurant Capital Management’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-77,929
Closed -$1.37M 86
2019
Q1
$1.37M Buy
+77,929
New +$1.66M 0.54% 47
2018
Q4
Sell
-310,596
Closed -$9.99M 77
2018
Q3
$9.99M Buy
310,596
+150,904
+94% +$5.15M 4.44% 4
2018
Q2
$5.62M Buy
159,692
+98,873
+163% +$3.65M 2.44% 16
2018
Q1
$2.41M Sell
60,819
-197,938
-76% -$7.69M 0.9% 29
2017
Q4
$9.46M Buy
258,757
+57,757
+29% +$2.19M 2.89% 9
2017
Q3
$8.2M Buy
201,000
+153,300
+321% +$5.94M 2.48% 11
2017
Q2
$1.9M Buy
47,700
+15,800
+50% +$529K 0.54% 46
2017
Q1
$928K Buy
+31,900
New +$842K 0.3% 68
2016
Q3
Sell
-60,016
Closed -$693K 106
2016
Q2
$693K Buy
60,016
+8,805
+17% +$103K 0.23% 67
2016
Q1
$517K Hold
51,211
0.17% 69
2015
Q4
$659K Sell
51,211
-23,689
-32% -$288K 0.22% 64
2015
Q3
$833K Buy
74,900
+54,900
+275% +$671K 0.28% 63
2015
Q2
$240K Buy
+20,000
New +$332K 0.07% 93

Other funds holding TVTY

Endurant Capital Management's TVTY Position: Q2 2019 in Review

Endurant Capital Management sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2019, closing a stake of 77,929 shares — an estimated $1.37M sold.

Endurant Capital Management first reported a position in TVTY in Q2 2015 and held it in 13 quarters. The position peaked at $9.99M in Q3 2018. 203 funds tracked by Wall St. Rank hold TVTY as of Q2 2019.

  • Endurant Capital Management reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Endurant Capital Management sold 77,929 Tivity Health, Inc. Common Stock shares in Q2 2019, an estimated $1.37M.
  • Endurant Capital Management first reported a position in Tivity Health, Inc. Common Stock in Q2 2015 and held it in 13 quarters.
  • Endurant Capital Management's Tivity Health, Inc. Common Stock position peaked at $9.99M in Q3 2018.
  • 203 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2019.

Based on Endurant Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.